Benoist, G. E., Hendriks, R. J., Mulders, P. F. A., Gerritsen, W. R., Somford, D. M., Schalken, J. A., . . . van Erp, N. P. (2016). Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide. Clin Pharmacokinet.
Chicago-stil citatBenoist, Guillemette E., Rianne J. Hendriks, Peter F. A. Mulders, Winald R. Gerritsen, Diederik M. Somford, Jack A. Schalken, Inge M. van Oort, David M. Burger, och Nielka P. van Erp. "Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide." Clin Pharmacokinet 2016.
MLA-referensBenoist, Guillemette E., et al. "Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide." Clin Pharmacokinet 2016.